<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - current issue</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of current issue</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:coverDisplayDate>June 2009</prism:coverDisplayDate>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1">
<title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep046</dc:identifier>
<dc:title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>131</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>129</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1">
<title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1</link>
<description><![CDATA[
<p>Static magnetic field (SMF) therapy, applied via a permanent magnet attached to the skin, is used by people worldwide for self-care. Despite a lack of established SMF dosage and treatment regimens, multiple studies are conducted to evaluate SMF therapy effectiveness. Our objectives in conducting this review are to:(i) summarize SMF research conducted in humans; (ii) critically evaluate reporting quality of SMF dosages and treatment parameters and (iii) propose a set of criteria for reporting SMF treatment parameters in future clinical trials. We searched 27 electronic databases and reference lists. Only English language human studies were included. Excluded were studies of electromagnetic fields, transcranial magnetic stimulation, magnets placed on acupuncture points, animal studies, abstracts, posters and editorials. Data were extracted on clinical indication, study design and 10 essential SMF parameters. Three reviewers assessed quality of reporting and calculated a quality assessment score for each of the 10 treatment parameters. Fifty-six studies were reviewed, 42 conducted in patient populations and 14 in healthy volunteers. The SMF treatment parameters most often and most completely described were site of application, magnet support device and frequency and duration of application. Least often and least completely described were characteristics of the SMF: magnet dimensions, measured field strength and estimated distance of the magnet from the target tissue. Thirty-four (61%) of studies failed to provide enough detail about SMF dosage to permit protocol replication by other investigators. Our findings highlight the need to optimize SMF dosing parameters for individual clinical conditions before proceeding to a full-scale clinical trial.</p>
]]></description>
<dc:creator><![CDATA[Colbert, A. P., Wahbeh, H., Harling, N., Connelly, E., Schiffke, H. C., Forsten, C., Gregory, W. L., Markov, M. S., Souder, J. J., Elmer, P., King, V.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem131</dc:identifier>
<dc:title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>139</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>133</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1">
<title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1</link>
<description><![CDATA[
<p>The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of &beta;-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of &beta;-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of &beta;-thalassemia patients, (iii) good correlation of <I>in vivo</I> and <I>in vitro</I> results of HbF synthesis and -globin mRNA accumulation indicates that <I>in vitro</I> testing might be predictive of <I>in vivo</I> responses and (iv) combined use of different inducers might be useful to maximize HbF, both <I>in vitro</I> and <I>in vivo</I>. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from <I>Angelica arcangelica</I> and <I>Aegle marmelos</I>, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from <I>Streptomyces hygroscopicus</I>.</p>
]]></description>
<dc:creator><![CDATA[Bianchi, N., Zuccato, C., Lampronti, I., Borgatti, M., Gambari, R.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem139</dc:identifier>
<dc:title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>151</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>141</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1</link>
<description><![CDATA[
<p>Since 1997, the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine of Graz Medical University has been dealing with the demystification of acupuncture and examining, using non-invasive methods, how different stimulation modalities (manual needle acupuncture, laserneedle acupuncture and electro acupuncture) affect peripheral and central functions. Laser is also an important instrument for acupuncture. One only needs to mention the treatment of children or of patients with needle phobia. The laserneedle acupuncture, which was examined scientifically for the first time in Graz, represents a new painless acupuncture method for which up to ten laserneedles are glued to the skin, but not stuck into it. This first part of the short review article summarizes some of the peripherally measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years.</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem145</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>158</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>153</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1">
<title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1</link>
<description><![CDATA[
<p>This is the final article in a four part series reviewing the influence of humor and laughter on physiological and psychological well-being. This final article reviews the evidence for the effect of sense of humor, exposure to a humor stimulus and laughter on various immune system components, with a focus on the effects of laughter on natural killer cell cytotoxicity.</p>
]]></description>
<dc:creator><![CDATA[Bennett, M. P., Lengacher, C.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem149</dc:identifier>
<dc:title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>164</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>159</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1">
<title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1</link>
<description><![CDATA[
<p>While the ancient Egyptians and Greeks used honey for wound care, and a broad spectrum of wounds are treated all over the world with natural unprocessed honeys from different sources, Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> has been one of the first medically certified honeys licensed as a medical product for professional wound care in Europe and Australia. Our experience with medical honey in wound care refers only to this product. In this review, we put our clinical experience into a broader perspective to comment on the use of medical honey in wound care. More prospective randomized studies on a wider range of types of wounds are needed to confirm the safety and efficacy of medical honey in wound care. Nonetheless, the current evidence confirming the antibacterial properties and additional beneficial effects of medical honey on wound healing should encourage other wound care professionals to use CE-certified honey dressings with standardized antibacterial activity, such as Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> products, as an alternative treatment approach in wounds of different natures.</p>
]]></description>
<dc:creator><![CDATA[Simon, A., Traynor, K., Santos, K., Blaser, G., Bode, U., Molan, P.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem175</dc:identifier>
<dc:title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>173</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>165</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1">
<title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1</link>
<description><![CDATA[
<p><I>Ki</I> (in Japanese) or <I>Qi</I> (in Chinese) is the key concept in Eastern medicine, Eastern philosophy, as well as in martial arts. We explain the philosophical and psychological background of <I>Ki</I>. We emphasize that the unique aspects of Eastern philosophy are &lsquo;non-linearity&rsquo; and &lsquo;holistic&rsquo; approach. We then present physics aspect of <I>Ki</I>. Our experiments demonstrated that a &lsquo;<I>Ki</I>-beam&rsquo; carries &lsquo;entropy&rsquo; (or information), which is different from &lsquo;energy&rsquo;. We introduce our experience of having taught <I>Ki</I> to 37 beginners in the United States through the Nishino Breathing Method. If beginners had martial arts training or a strong background in music or dance, about half of them could sense <I>Ki</I> within 10 weeks (1 h class per week) of practice.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen005</dc:identifier>
<dc:title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>183</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>175</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1">
<title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1</link>
<description><![CDATA[
<p>Acupuncture is an ancient Chinese therapy with its mode of action unclear and efficacy inconclusive. A lack of attention given to the role of psychosocial context presented in clinical provision of acupuncture may mainly account for the current dilemma in acupuncture research. This psychosocial context induces various cognitive and affective processes in the patient while receiving this treatment. On the basis of the analysis of these psychological factors involved in clinical provision of acupuncture and in light of prior studies on the placebo effect, the author hypothesizes that acupuncture works through potentiation and modulation of a highly organized and somatotopic network of endogenous opioids that links expectation, attention and body schema. This hypothesis, which focuses on the contextual factors involved in clinical provision of acupuncture, has immediate clinical and experimental implications and will take the acupuncture debate much further forward.</p>
]]></description>
<dc:creator><![CDATA[Liu, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen002</dc:identifier>
<dc:title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>193</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>185</prism:startingPage>
<prism:section>Hypothesis</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1">
<title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1</link>
<description><![CDATA[
<p>Licorice is commonly used as a cure for digestive disorders and as a detoxification agent in East Asia. This study investigated the protective effect of licorice water extract against cadmium (CdCl<SUB>2</SUB>, Cd)-induced liver toxicity in rats. To induce acute toxicity, Cd (4 mg/kg body weight) was dissolved in normal saline and intravenously (i.v.) injected into rats. The rats then received either a vehicle or licorice water extract (50, 100 mg/kg/day) for 3 days, and were subsequently exposed to a single injection of Cd 24 h after the last licorice/vehicle treatment. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) were significantly increased by Cd treatment. In contrast, pretreatment with licorice reduced ALT, AST and LDH. In histopathological analysis, licorice decreased the central necrosis around central veins, the peripheral hemorrhage around portal triads, the percentage of degenerative hepatic regions (%/mm<sup>2</sup> hepatic parenchyma) and the number of degenerative hepatic cells (<I>N</I>/100 hepatic cells). Licorice also inhibited the increment of Bad (a BH3 domain-containing protein) translocation by Cd in liver cells. These results demonstrate that licorice could have a hepatoprotective effect by inhibiting the translocation of Bad to the mitochondria in Cd-intoxificated rats.</p>
]]></description>
<dc:creator><![CDATA[Lee, J. R., Park, S. J., Lee, H.-S., Jee, S. Y., Seo, J., Kwon, Y. K., Kwon, T. K., Kim, S. C.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem078</dc:identifier>
<dc:title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>201</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>195</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1">
<title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1</link>
<description><![CDATA[
<p>C<I>entella asiatica</I> (CeA) is a creeping herb, growing in moist places in India and other Asian Countries. Ayurvedic system of medicine, an alternate system of medicine in India, uses leaves of CeA for memory enhancement. Here, we have investigated the role of CeA fresh leaf juice treatment during growth spurt period of rats on dendritic morphology of amygdaloid neurons, one of the regions concerned with learning and memory. The present study was conducted on neonatal rat pups. The rat pups (7-days-old) were fed with 2, 4 and 6 ml/kg body of fresh leaf juice of CeA for 2, 4 and 6 weeks. After the treatment period, the rats were killed, brains removed and amygdaloid neurons impregnated with Silver nitrate (Golgi staining). Amygdaloid neurons were traced using camera lucida and dendritic branching points (a measure of dendritic arborization) and intersections (a measure dendritic length) quantified. These data were compared with those of age-matched control rats. The results showed a significant increase in dendritic length (intersections) and dendritic branching points along the length of dendrites of the amygdaloid neurons of rats treated with 4 and 6 ml/kg body weight/day of CeA for longer periods of time (i.e. 4 and 6 weeks). We conclude that constituents/active principles present in CeA fresh leaf juice has neuronal dendritic growth stimulating property; hence it can be used for enhancing neuronal dendrites in stress and other neurodegenerative and memory disorders.</p>
]]></description>
<dc:creator><![CDATA[Mohandas Rao, K. G., Muddanna Rao, S., Gurumadhva Rao, S.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem079</dc:identifier>
<dc:title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>210</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>203</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1">
<title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1</link>
<description><![CDATA[
<p>Tibetan medicated-bath therapy has been applied to patients with rheumatoid arthritis for centuries. However, the detailed action mechanism of Tibetan medicated-bath therapy on the morphology and function of joints remains unknown. We designed our investigation to evaluate the efficacy of Tibetan medicated-bath therapy on adjuvant arthritis (AA) of rats in comparison with water-bath and dexamethasone administration. AA was induced by intradermal injection of <I>Mycobacterium butyricum</I> suspended in sterile mineral oil. The control animals were similarly injected with sterile vehicle. Eight days after injection, rats were treated with fresh-water bath, Tibetan medicated-bath (40&deg;C, 15 min) or intramuscular injection with dexamethasone for 21 consecutive days after which we evaluated the severity of arthritis visually and microscopically and measured serum interleukin (IL)-6 and tumor necrosis factor (TNF)- levels. While arthritis did not significantly change after water-bath treatment, the Tibetan medicated-bath and dexamethasone groups showed diminished joint swelling and alleviation of, inflammatory cell infiltration and the destruction of bone and cartilage. Serum IL-6 and TNF- levels significantly decreased. Our results demonstrated that Tibetan medicated-bath therapy exerted a reliable effect on rat adjuvant arthritis, which may be involved in the inflammatory cytokines, IL-6 and TNF-. Our data provide evidence for clinical use of Tibetan-medicated bath therapy for arthritis patients.</p>
]]></description>
<dc:creator><![CDATA[Chen, H., Shoumura, S., Emura, S., Isono, H.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem083</dc:identifier>
<dc:title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>217</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>211</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1">
<title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1</link>
<description><![CDATA[
<p>Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular diseases. Root of <I>Asparagus racemosus</I> (AR) is widely used in Ayurvedic system of medicine in India and is known for its steroidal saponin content. This study was designed to investigate the hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholesteremic animals. Normal and hypercholesteremic male albino rats were administered with root powder of AR (5 and 10 g% dose levels) along with normal and hypercholesteremic diets, respectively, for a duration of 4 weeks. Plasma and hepatic lipid profiles, fecal sterol, bile acid excretion and hepatic antioxidant activity were assessed. Inclusion of AR root powder in diet, resulted in a dose-dependant reduction in plasma and hepatic lipid profiles, increased fecal excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA reductase activity and bile acid content in hypercholesteremic rats. Further, AR root also improved the hepatic antioxidant status (catalase, SOD and ascorbic acid levels). No significant changes in lipid and antioxidant profiles occurred in the normocholesteremic rats administered with AR root powder. AR root appeared to be useful as a dietary supplement that offers a protection against hyperlipidemia/hypercholesteremia in hypercholesteremic animals. The results of the present study indicate that the potent therapeutic phyto-components present in AR root i.e. phytosterols, saponins, polyphenols, flavonoids and ascorbic acid, could be responsible for increased bile acid production, elimination of excess cholesterol and elevation of hepatic antioxidant status in hypercholesteremic conditions.</p>
]]></description>
<dc:creator><![CDATA[Visavadiya, N. P., Narasimhacharya, A. V. R. L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem091</dc:identifier>
<dc:title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>226</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>219</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1">
<title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1</link>
<description><![CDATA[
<p>The antioxidant activities of crude extract of <I>Phaulopsis fascisepala</I> leaf were evaluated and compared with -tocopherol and BHT as synthetic antioxidants and ascorbic acid as natural-based antioxidant. <I>In vitro</I>, we studied its antioxidative activities, radical-scavenging effects, Fe<sup>2+</sup>-chelating ability and reducing power. The total phenolic content was determined and expressed in gallic acid equivalent. The extract showed variable activities in all of these <I>in vitro</I> tests. The antioxidant effect of <I>P. fascisepala</I> was strongly dose dependent, increased with increasing leaf extract dose and then leveled off with further increase in extract dose. Compared to other antioxidants used in the study, -Tocopherol, ascorbic acid and BHT, <I>P. fascisepala</I> leaf extract showed less scavenging effect on ,,-diphenyl-&beta;-picrylhydrazyl (DPPH) radical and less reducing power on Fe<sup>3+</sup>/ferricyanide complex but better Fe<sup>2+</sup>-chelating ability. These results revealed the <I>in vitro</I> antioxidant activity of <I>P</I>. <I>fascisepala.</I> Further investigations are necessary to verify these activities <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Adesegun, S. A., Fajana, A., Orabueze, C. I., Coker, H. A. B.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem098</dc:identifier>
<dc:title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>231</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1">
<title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1</link>
<description><![CDATA[
<p>The role of abrin, a toxic lectin isolated from seeds of <I>Abrus precatorius</I> Linn in inducing apoptosis in murine Dalton's Lymphoma Ascites (DLA) cells was evaluated. Abrin when incubated at the concentration of 10 ng per million DLA cells could bring about cell death as typical morphological changes with apoptosis. However, necrotic cell death dominated when a higher dose of abrin was used. DNA samples, isolated from DLA cells treated with abrin showed fragmentation. Abrin brought about induction of apoptosis by stimulating the expression of pro-apoptotic Caspase-3, at the same time blocking the expression of Bcl-2, which is an anti apoptotic gene. However, the expression of tumor suppressor gene p53 has not been observed in control and abrin-treated DLA cells. Results suggested that abrin effectively induced apoptotic changes in the tumor cells that led to cellular death.</p>
]]></description>
<dc:creator><![CDATA[Ramnath, V., Rekha, P. S., Kuttan, G., Kuttan, R.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem099</dc:identifier>
<dc:title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>238</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>233</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1">
<title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1</link>
<description><![CDATA[
<p>Using an adjuvant-induced arthritis rat model, we investigated the effects of a lipid extract of <I>Perna canaliculus</I> (Lyprinol&reg;) on pain. Radiological examinations, as well as levels of pro- and anti-inflammatory (AI) cytokines, were measured aiming to provide independent objective data to the pain controlling investigation. We confirmed the ability of Lyprinol&reg; to control pain at the initial phase of its administration; with similar efficacy to that observed with Naproxen. The pain scores slowly increased again in the group of rats treated with Lyprinol&reg; after day 9&ndash;14. The Naproxen-treated rats remained pain-free while treated. Both Naproxen and Lyprinol&reg; decreased the levels of the pro-inflammatory cytokines TNF- and IFN-, and increased that of IL-10. Extra-virgin olive oil was ineffective on cytokine secretion. Rats treated with Lyprinol&reg; were apparently cured after 1 year. This study confirms the AI efficacy of this lipid extract of <I>P. canaliculus</I>, its initial analgesic effect, its perfect tolerance and its long-term healing properties.</p>
]]></description>
<dc:creator><![CDATA[Lee, C.-H., Lum, J. H.-K., Ng, C. K.-C., McKay, J., Butt, Y. K.-C., Wong, M.-S., Lo, S. C.-L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem100</dc:identifier>
<dc:title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>245</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>239</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1">
<title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to investigate the efficacy of four different Japanese and Chinese herbal prescriptions, Ren-Shen-Yang-Rong-Tang (Ninjin&rsquo;yoeito, NYT), Chai-Hu-Gui-Zhi-Gan-Jiang-Tang (Saikokeishikankyoto, SKKT), Si-Jun-Zi-Tang (Shikunshito, SKT) and Si-Wu-Tang (Shimotsuto, SMT), which are traditionally used for anemia and fatigue, against hematotoxicity in mice treated with 5-fluorouracil (5-FU). NYT 1&ndash;100 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup> injected orally for 7 consecutive days before and after 5-FU injection significantly suppressed reductions in red blood cell, white blood cell and platelet counts in peripheral blood, and accelerated their recovery. Administration of SKKT also produced a slight but significant improvement in 5-FU-induced erythrocytopenia, whereas SMT and SKT could not prevent anemia. Oral injection of NYT also inhibited 5-FU-induced decreases in peripheral reticulocyte and bone marrow cell counts on day 10, and markedly hastened their recovery on day 20, in a dose-dependent manner. Erythroid progenitor colonies, such as colony forming units-erythroid and burst forming units-erythroid, formed by marrow cells from mice treated with 5-FU were significantly increased by oral administration of NYT. These findings suggest that NYT has the potential to protect against hematotoxicity, and also has hematopoietic activity, through stimulation of immature erythroid progenitor cell differentiation.</p>
]]></description>
<dc:creator><![CDATA[Takano, F., Ohta, Y., Tanaka, T., Sasaki, K., Kobayashi, K., Takahashi, T., Yahagi, N., Yoshizaki, F., Fushiya, S., Ohta, T.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem080</dc:identifier>
<dc:title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>256</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>247</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1">
<title><![CDATA[Dynamized Preparations in Cell Culture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1</link>
<description><![CDATA[
<p>Although reports on the efficacy of homeopathic medicines in animal models are limited, there are even fewer reports on the <I>in vitro</I> action of these dynamized preparations. We have evaluated the cytotoxic activity of 30C and 200C potencies of ten dynamized medicines against Dalton's Lymphoma Ascites, Ehrlich's Ascites Carcinoma, lung fibroblast (L929) and Chinese Hamster Ovary (CHO) cell lines and compared activity with their mother tinctures during short-term and long-term cell culture. The effect of dynamized medicines to induce apoptosis was also evaluated and we studied how dynamized medicines affected genes expressed during apoptosis. Mother tinctures as well as some dynamized medicines showed significant cytotoxicity to cells during short and long-term incubation. Potentiated alcohol control did not produce any cytotoxicity at concentrations studied. The dynamized medicines were found to inhibit CHO cell colony formation and thymidine uptake in L929 cells and those of <I>Thuja</I>, <I>Hydrastis</I> and <I>Carcinosinum</I> were found to induce apoptosis in DLA cells. Moreover, dynamized Carcinosinum was found to induce the expression of p53 while dynamized Thuja produced characteristic laddering pattern in agarose gel electrophoresis of DNA. These results indicate that dynamized medicines possess cytotoxic as well as apoptosis-inducing properties.</p>
]]></description>
<dc:creator><![CDATA[Sunila, E. S., Kuttan, R., Preethi, K. C., Kuttan, G.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem082</dc:identifier>
<dc:title><![CDATA[Dynamized Preparations in Cell Culture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>263</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>257</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1">
<title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1</link>
<description><![CDATA[
<p>Traditional Chinese Medicine practitioners consider that chronic fatigue reflects a disharmony and depletion in the supply of <I>qi</I> in the body. Qigong is one of the traditional complementary interventions used to strengthen <I>qi</I> through self-practice, and to manage the state of <I>qi</I> to prevent and cure disease. The aim of this study is to assess whether qigong could be used to manage the symptoms of chronic fatigue. Eighteen Caucasian, British female participants were recruited, taught a qigong routine during weekly classes over 6 months, and asked to practice it daily for 15 min. Participants completed the core set of the RAND Medical Outcomes Study questionnaire (RAND MOS) and a sleep diary during the 2-week baseline control period, and at 3 and 6 months following the start of the trial. The qigong intervention resulted in significant changes in sleep rate score and in the following subscales of the RAND MOS: SF36 Vitality, Sleep Problems, Social Activity, Social Activity Limitation due to Health, Health Distress, Mental Health Index and Psychological Well-being. Qigong seems to improve factors related to chronic fatigue such as sleep, pain, mental attitude and general mobility after 3 and 6 months. Qigong's positive effects indicate that it represents a potentially safe method of treatment for chronic fatigued patients. However, we cannot completely discount the possible influence of placebo effects, and more objective clinical measures are needed to reproduce our findings with long-term follow-up in a randomized, controlled study involving a larger number of subjects.</p>
]]></description>
<dc:creator><![CDATA[Craske, N. J. M., Turner, W., Zammit-Maempe, J., Lee, M. S.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem088</dc:identifier>
<dc:title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>270</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>265</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1">
<title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1</link>
<description><![CDATA[
<p>Although there are many clinical programs designed to bring humor into pediatric hospitals, there has been very little research with children or adolescents concerning the specific utility of humor for children undergoing stressful or painful procedures. Rx Laughter<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP>, a non-profit organization interested in the use of humor for healing, collaborated with UCLA to collect preliminary data on a sample of 18 children aged 7&ndash;16 years. Participants watched humorous video-tapes before, during and after a standardized pain task that involved placing a hand in cold water. Pain appraisal (ratings of pain severity) and pain tolerance (submersion time) were recorded and examined in relation to humor indicators (number of laughs/smiles during each video and child ratings of how funny the video was). Whereas humor indicators were not significantly associated with pain appraisal or tolerance, the group demonstrated significantly greater pain tolerance while viewing funny videos than when viewing the videos immediately before or after the cold-water task. The results suggest that humorous distraction is useful to help children and adolescents tolerate painful procedures. Further study is indicated to explore the specific mechanism of this benefit.</p>
]]></description>
<dc:creator><![CDATA[Stuber, M., Hilber, S. D., Mintzer, L. L., Castaneda, M., Glover, D., Zeltzer, L.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem097</dc:identifier>
<dc:title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>276</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>271</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1">
<title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1</link>
<description><![CDATA[
<p>Two consecutive conferences on &lsquo;Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine&rsquo; were held in Xinjiang Medical University on July 3 and Kanazawa Medical University on October 6, 2007. The Vice president Halmurat Upur presided over the meeting and gave congratulatory address on holding of the conference. In order to understand mutually and discuss the possibility of the Uighur Medicine as CAM and the situation of medicine in the global sense, specialist scholars of Traditional Uighur Medicine and postgraduates attended this conference. In the meeting of the CAM, the achievements on the research of Traditional Uighur Medicine were exchanged and warmly discussed. Presentations were made in the consecutive conference.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Yamaguchi, N.]]></dc:creator>
<dc:date>2009-05-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen012</dc:identifier>
<dc:title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>278</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>277</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

</rdf:RDF>